top of page

2022 Rome Action Plan on Paediatric HIV & TB

Catholic Relief Services

HIV MEDICINES DURING PREGNANCY AND BREASTFEEDING

Catholic Relief Services commits to:

75. Continue working with in-country partners and stakeholders to raise awareness, demand, and support for women and children during pregnancy and breastfeeding, and support policies and standards of practice improving maternal retesting.

Updates

-

HIV DIAGNOSTICS

Faith Based Organizations commit to:

153. Equip, mobilize, and support faith leaders, FBOs, people in places of worship, and the wider community to create demand for testing of infants and children.

154. Combat stigma and discrimination among faith leaders and within communities of faith.

155. Further collaborate and coordinate community mobilization, education and outreach to find otherwise hard-to-reach children, adolescents, youth and adults for age-appropriate prevention education, testing and linkage to treatment, health and social support services and integrate into the national system.

Catholic Relief Services commits to:

157. Continue working with in-country partners and stakeholders to improve case-finding and optimize testing strategies for children, adolescent girls and young women, and adults.

158. Continue to advocate for and support efforts to strengthen community-facility linkages, and improved collaboration and integration between health and social welfare service providers.

All partners commit to:

163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment.

164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care.

165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.

166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil

society to monitor progress regarding uptake and implementation of essential diagnostic tools.

Updates

 - 

TB DIAGNOSTICS

Faith Based Organisations commit to:

216. Support and participate in national efforts to improve the uptake of paediatric diagnostics for TB and HIV, ensuring that communities are educated and informed on health risks and the need for early health access as well as reducing stigma.

217. Introduce initiatives aimed at reducing catastrophic costs on individuals by providing financial and operational support (e.g., sample collection and delivery) to vulnerable populations to access essential screening and diagnostic services.

Updates

 - 

HIV MEDICINES FOR CHILDREN

Catholic Relief Services commits to:

353. Continue supporting in-country partners reaching families, communities, social welfare service providers, and community and facility-based health providers to improve treatment literacy, and provide holistic support and strengthened case management practices to improve treatment

coverage, adherence, and viral load suppression for children living with HIV.

354. Continue addressing social and structural barriers inhibiting access to testing and treatment services for children living with HIV.

355. Continue community engagement and empowerment efforts supporting community led quality of service monitoring for children affected by HIV.

Updates

 -

TB TREATMENT for CHILDREN, PREGNANT, POST-PARTUM AND BREASTFEEDING WOMEN

EGPAF commits to:

464. Improve the proportion of children and adolescents living with HIV (CALHIV) initiating and completing TB preventive treatment (TPT) among newly diagnosed CALHIV who access care at EGPAF supported facilities. 

 

465. Improve the proportion of CALHIV that are identified as presumptive TB as well as the proportion finally diagnosed with TB among the CALHIV who access care at EGPAF supported facilities. Improve the linkage to TB treatment initiation among those diagnosed with TB.

 

466. Develop a paediatric and adolescent TB monitoring and evaluation framework for patient level and programmatic level indicators.

 

467. At least three public events and/or advocacy products led or co-led by EGPAF in collaborations with other TB stakeholders to sensitize, increase awareness and advocate for childhood TB at the national, regional and global levels in 2023.

 

468. Provide technical support to National TB Programs for policy change to adopt the new child and adolescents TB guidelines and recommendations released by WHO in 2022.

Updates

 - 

bottom of page